MRM-based LC-MS method for accurate C-peptide quantitation
Open Access
- 1 April 2025
- journal article
- Published by Stanford University Press in Journal of Mass Spectrometry and Advances in the Clinical Lab
- Vol. 36, 1-8
Abstract
C-peptide secretion mirrors beta-cell function and has emerged as a valuable clinical biomarker for diabetes mellitus. C-peptide measurements can provide estimates of insulin secretory capacity, aiding in clinical decision-making and differentiation between diabetes types. Unfortunately, C-peptide assays are still not standardized, which may limit their practical clinical use. We have developed an MRM-based LC-MS method that demonstrated accuracy close to our reference method. To develop and validate a mass spectrometry method for accurate quantitation of C-peptide. A serum sample was spiked with isotope-labeled C-peptide as a standard. The enrichment process involved protein precipitation with methanol, solid-phase extraction, and anion exchange for C-peptide enrichment followed by Glu-C digestion. The peptide LGGGPGAGSLQPLALE was quantitated using MRM in positive ion mode. The calibration process includes C-peptide CRM material to ensure a complete traceability chain for the measurement. The assay exhibited linearity across a wide range of C-peptide concentrations and a limit of quantitation of 0.058 nmol/L. The inter-day imprecision was less than 9.6 % CV, and the intra-day imprecision was less than 8.9 % CV. Spiking with bilirubin, triglycerides, and hemoglobin demonstrated no interference, except for triglycerides at very high levels. The method exhibited a strong correlation to the C-peptide reference method (r2 = 0.95). The developed mass spectrometry method has demonstrated accurate results in C-peptide quantitation and can serve as a supplemental method to the existing C-peptide reference method. This ensures sustained stability over time and ultimately refines the existing reference system.Keywords
Funding Information
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (1UC4DK096587-01)
This publication has 17 references indexed in Scilit:
- Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and InsulinClinical Chemistry, 2024
- Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes MellitusClinical Chemistry, 2023
- Critical need to assess modified and un-modified peptides in C-peptide standard materialsJournal of Mass Spectrometry and Advances in the Clinical Lab, 2022
- Multiplexed quantification of insulin and C-peptide by LC-MS/MS without the use of antibodiesJournal of Mass Spectrometry and Advances in the Clinical Lab, 2022
- Development and validation of a novel LC-MS/MS assay for C-peptide in human serumJournal of Mass Spectrometry and Advances in the Clinical Lab, 2020
- Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetesDiabetologia, 2020
- Recent advances in mass spectrometric analysis of protein deamidationMass Spectrometry Reviews, 2016
- Two‐step ion‐exchange chromatographic purification combined with reversed‐phase chromatography to isolate C‐peptide for mass spectrometric analysisJournal of Separation Science, 2015
- Low levels of C‐peptide have clinical significance for established Type 1 diabetesDiabetic Medicine, 2015
- Development of C-reactive protein certified reference material NMIJ CRM 6201-b: optimization of a hydrolysis process to improve the accuracy of amino acid analysisAnalytical and Bioanalytical Chemistry, 2014